1. Inicio
  2. FORMACIÓN
  3. Programa de Seminarios Internos
  4. PhD Defense: A2B Adenosine Receptor as a novel target in cancer immunotherapy: Validation and optimization of new ligands
Defensa de Tesis

PhD Defense: A2B Adenosine Receptor as a novel target in cancer immunotherapy: Validation and optimization of new ligands

Mr. Rubén Prieto Díaz

06-10-2023

Facultad de Farmacia - Salón de Grados